Mice lacking TR4 nuclear receptor develop mitochondrial myopathy with deficiency in complex I.

Su Liu,Yi-Fen Lee,Samuel Chou,Hideo Uno,Gonghui Li,Paul Brookes,Michael P Massett,Qiao Wu,Lu-Min Chen,Chawnshang Chang
DOI: https://doi.org/10.1210/me.2010-0455
2011-01-01
Molecular Endocrinology
Abstract:The estimated incidence of mitochondrial diseases in humans is approximately 1:5000 to 1:10,000, whereas the molecular mechanisms for more than 50% of human mitochondrial disease cases still remain unclear. Here we report that mice lacking testicular nuclear receptor 4 (TR4(-/-)) suffered mitochondrial myopathy, and histological examination of TR4(-/-) soleus muscle revealed abnormal mitochondrial accumulation. In addition, increased serum lactate levels, decreased mitochondrial ATP production, and decreased electron transport chain complex I activity were found in TR4(-/-) mice. Restoration of TR4 into TR4(-/-) myoblasts rescued mitochondrial ATP generation capacity and complex I activity. Further real-time PCR quantification and promoter studies found TR4 could modulate complex I activity via transcriptionally regulating the complex I assembly factor NDUFAF1, and restoration of NDUFAF1 level in TR4(-/-) myoblasts increased mitochondrial ATP generation capacity and complex I activity. Together, these results suggest that TR4 plays vital roles in mitochondrial function, which may help us to better understand the pathogenesis of mitochondrial myopathy, and targeting TR4 via its ligands/activators may allow us to develop better therapeutic approaches. (Molecular Endocrinology 25: 1301-1310, 2011)
What problem does this paper attempt to address?